ArticleCancer research communications2024

The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner.

Joseph Mazar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.